OLMA
Price
$25.73
Change
-$0.41 (-1.57%)
Updated
Feb 4, 03:08 PM (EDT)
Capitalization
2.1B
26 days until earnings call
Intraday BUY SELL Signals
VNDA
Price
$7.65
Change
-$0.40 (-4.97%)
Updated
Feb 4, 03:26 PM (EDT)
Capitalization
475.73M
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OLMA vs VNDA

Header iconOLMA vs VNDA Comparison
Open Charts OLMA vs VNDABanner chart's image
Olema Pharmaceuticals
Price$25.73
Change-$0.41 (-1.57%)
Volume$393
Capitalization2.1B
Vanda Pharmaceuticals
Price$7.65
Change-$0.40 (-4.97%)
Volume$500
Capitalization475.73M
OLMA vs VNDA Comparison Chart in %
OLMA
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OLMA vs. VNDA commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OLMA is a Hold and VNDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (OLMA: $26.14 vs. VNDA: $8.05)
Brand notoriety: OLMA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OLMA: 74% vs. VNDA: 63%
Market capitalization -- OLMA: $2.1B vs. VNDA: $475.73M
OLMA [@Biotechnology] is valued at $2.1B. VNDA’s [@Biotechnology] market capitalization is $475.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OLMA’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • OLMA’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both OLMA and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OLMA’s TA Score shows that 2 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • OLMA’s TA Score: 2 bullish, 5 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VNDA is a better buy in the short-term than OLMA.

Price Growth

OLMA (@Biotechnology) experienced а +0.15% price change this week, while VNDA (@Biotechnology) price change was +0.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

OLMA is expected to report earnings on Mar 02, 2026.

VNDA is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OLMA($2.1B) has a higher market cap than VNDA($476M). OLMA YTD gains are higher at: 4.560 vs. VNDA (-8.730). VNDA has higher annual earnings (EBITDA): -113.07M vs. OLMA (-164.96M). OLMA has more cash in the bank: 329M vs. VNDA (294M). OLMA has less debt than VNDA: OLMA (4.48M) vs VNDA (10.9M). VNDA has higher revenues than OLMA: VNDA (212M) vs OLMA (0).
OLMAVNDAOLMA / VNDA
Capitalization2.1B476M440%
EBITDA-164.96M-113.07M146%
Gain YTD4.560-8.730-52%
P/E RatioN/A126.00-
Revenue0212M-
Total Cash329M294M112%
Total Debt4.48M10.9M41%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OLMAVNDA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 21 days ago
86%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 10 days ago
69%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
OLMA
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMUCX13.300.15
+1.14%
Columbia Select Mid Cap Value C
DRLAX8.990.04
+0.45%
BNY Mellon Developed Markets RE Scs - A
BUIOX16.97-0.09
-0.53%
Buffalo Early Stage Growth Instl
PGLRX19.02-0.15
-0.78%
Putnam Focused International Equity R
VAFIX30.12-0.53
-1.73%
Invesco American Franchise Y

OLMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, OLMA has been loosely correlated with ARWR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OLMA jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OLMA
1D Price
Change %
OLMA100%
+1.91%
ARWR - OLMA
43%
Loosely correlated
-1.18%
IPSC - OLMA
42%
Loosely correlated
N/A
NUVL - OLMA
42%
Loosely correlated
+2.12%
AVBP - OLMA
42%
Loosely correlated
-0.15%
EYPT - OLMA
42%
Loosely correlated
-3.69%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IVF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+4.01%
IVF - VNDA
40%
Loosely correlated
-6.45%
OLMA - VNDA
37%
Loosely correlated
+1.91%
MGTX - VNDA
37%
Loosely correlated
+2.68%
VCYT - VNDA
36%
Loosely correlated
-1.10%
JAZZ - VNDA
36%
Loosely correlated
-0.27%
More